Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Spinal Cord Injury Therapeutics Market, by Injury Type (Complete Spinal Cord Injury and Incomplete Spinal Cord Injury), By Drug Type (Corticosteroids, Muscle Relaxants, and Anti-spastic drugs, Non-steroidal Anti-inflammatory Drugs ( NSAID’S), Anti-depressants, Anticonvulsants, and Others), By Application (Autonomic Dysreflexia (AD), Spasticity & Inflammation, Pain Management, and Depression), By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 6,630.7 million in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/4305
Rising government investments in key companies to promote research and development for treatment of spinal cord injuries is expected to drive the global spinal cord injury therapeutics market. For instance, in 2018, BioAxone BioSciences, Inc. announced that they received two-year grant of US$ 1.1 Million, which provides funding for further development of BioAxone’s preclinical candidate BA-434, a novel sd-rxRNA compound that targets phosphatase and tensin homolog (PTEN) for the treatment of spinal cord injury (SCI). The funding was granted from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the U.S. National Institutes of Health.
Global Spinal Cord Injury Therapeutics Market – Impact of Coronavirus (COVID-19)
- The COVID-19 pandemic has drastically impacted each and every market across the world. Therefore, academic institutes are taking initiatives to combat spinal cord injury amid Covid-19.
- In order to manage spinal cord injury patients during the COVID-19 pandemic, various academic institutes and companies are taking initiatives to combat various difficulties faced by individuals such as shortage of personal healthcare attendant and health care treatments for individuals suffering from spinal cord injuries during the COVID-19 pandemic. For instance, in May 2020, United Spinal Association, a nonprofit membership, disability rights, and veterans service organization deployed a United Spinal’s Policy department, which keeps track and informs Washington, DC, state officials and legislators about the gaps created by COVID-19 in services to individuals suffering from spinal cord injury and also ensure United spinal association members have access to healthcare and community supports.
The market is expected to witness significant growth during the forecast period, owing to key players focusing on research and development for the treatment of spinal cord injury. For instance, in 2019, BioArctic AB, a Sweden-based research-based biopharmaceutical company, announced that they are currently in phase 2 clinical trial of investigation study on treatment of spinal cord injury with its product candidate SC0806 and also stated that they have initiated enrolling of subjects to study the efficacy and safety of product.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/4305
Key Takeaways of the Global Spinal Cord Injury Therapeutics Market:
- The global spinal cord injury therapeutics market is expected to exhibit a CAGR of 6.7% during the forecast period, owing to key companies focusing on research and development for the treatment of spinal cord injury.
- Among injury type, complete spinal cord injury segment is estimated to hold major market share in the global spinal cord injury therapeutics market during the forecast period, owing to increasing prevalence of complete spinal cord injury in individuals globally. According to World Health Organization report published in 2014, stated that approximately 2500000 to 500000 individuals are affected by spinal cord injury globally each year.
- Among drug type, corticosteroids segment is estimated to hold major market share in the global spinal cord injury therapeutics market during the forecast period, owing to key companies focusing on treatment of spinal cord injuries with the corticosteroids due to its efficacy. According to US National Library of Medicine Report published in February 2020, stated that high dose of methylprednisolone is effective in the treatment of spinal cord injury.
- Key players operating in the global spinal cord injury therapeutics market include ReNetX Bio, InVivo Therapeutics Hldg, GTX Medical, Acorda Therapeutics, Lineage Cell Therapeutics, AbbVie Inc., Asterias Biotherapeutics, Inc, BioArctic, Kringle Pharma, Inc., Pfizer Inc., Pharmicell Co., Ltd., Bioaxone Biosciences, Inc., Vertex Pharmaceuticals Inc., Biogen Inc., RespireRx Phamaceuticals Inc., NervGen, Lannett Co Inc, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, MSN Laboratories Private Limited, Rising Pharmaceuticals, Inc., ScieGen Pharmaceuticals, Inc, and Cadila Healthcare Limited.
Browse 33 Market Data Tables and 32 Figures spread through 175 Pages and in-depth TOC on “Global Spinal Cord Injury Therapeutics Market, by Injury Type (Complete Spinal Cord Injury and Incomplete Spinal Cord Injury), By Drug Type (Corticosteroids, Muscle Relaxants and Anti-spastic drugs, Non-steroidal Anti-inflammatory Drugs ( NSAID’S), Anti-depressants, Anticonvulsants, and Others), By Application ( Autonomic Dysreflexia (AD), Spasticity & Inflammation, Pain Management, and Depression), By Route of Administration (Oral and Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)”
To know the latest trends and insights prevalent in the global spinal cord injury therapeutics market press release, click the link below: https://www.coherentmarketinsights.com/press-release/spinal-cord-injury-therapeutics-market-3568
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Injury Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Developments
- New Product Launches/Approvals
- Merger-Acquisition Scenario
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- PEST Analysis
- Reimbursement
- Global Spinal Cord Injury Therapeutics Market – Impact of COVID-19 Pandemic
- Government Initiative To Combat Covid-19
- COVID 19 Impact on Overall Healthcare Market
- COVID 19 Impact on Spinal Cord Market
- Global Spinal Cord Injury Therapeutics Market, By Injury Type, 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Complete Spinal Cord Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Incomplete Spinal Cord Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Complete Spinal Cord Injury
- Introduction
- Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Muscle Relaxants and Anti-spastic drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Non-steroidal Anti-inflammatory drugs ( NSAID’S)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Anti-depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Corticosteroids
- Introduction
- Global Spinal Cord Injury Therapeutics Market, By Application, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Autonomic Dysreflexia (AD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Spasticity & Inflammation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Autonomic Dysreflexia (AD)
- Introduction
- Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Oral
- Introduction
- Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Hospital Pharmacies
- Introduction
- Global Spinal Cord Injury Therapeutics Market, By Region, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Countries, 2017–2027
- North America
- Latin Americ
- Europe
- Asia Pacific
- Middle East
- Africa
- Introduction
- Competitive Landscape
- Company Profiles
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
